About Amaryllis Therapeutics
Amaryllis Therapeutics is a private company based in Cambridge, Massachusetts, incorporated in 2024 in Delaware. It has reported $1,500,000 raised in one offering on Form D since September 2024. Its chief executive is Jeongseuk Kang.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 10, 2024 | Sep 18, 2024 | $1,500,000fully sold | 1 | $1.5M | OptionsRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Amaryllis Therapeutics's Form D filed Sep 18, 2024.
JK
Jeongseuk Kang
Chief Executive Officer and director
EK
Emmanouil Karagiannis
Director